Epidemiology and Natural History of Inflammatory Bowel Diseases, Gastroenterology, vol.140, issue.6, pp.1785-1794, 2011. ,
DOI : 10.1053/j.gastro.2011.01.055
URL : https://hal.archives-ouvertes.fr/hal-00631553
Morbid appearances in the intestines of Miss Bankes Lond Med Gaz, pp.264-265, 1859. ,
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis, Journal of Crohn's and Colitis, vol.8, issue.76, pp.965-90, 2012. ,
DOI : 10.1097/00054725-200201000-00003
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working, 2005. ,
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee, The American Journal of Gastroenterology, vol.4, issue.3, pp.501-524, 2010. ,
DOI : 10.1016/0016-5085(92)90831-I
REGIONAL ILEITIS, Journal of the American Medical Association, vol.99, issue.16, pp.1323-1332, 1932. ,
DOI : 10.1001/jama.1932.02740680019005
Diagnosing Colitis: a Prospective Study on Essential Parameters for Reaching a Diagnosis, Endoscopy, vol.35, issue.12, pp.1004-1012, 2003. ,
DOI : 10.1055/s-2003-44593
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, vol.55, issue.6, pp.749-53, 2006. ,
DOI : 10.1136/gut.2005.082909
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review, Gastroenterology, vol.142, issue.1, pp.46-54, 2012. ,
DOI : 10.1053/j.gastro.2011.10.001
The Prevalence and Geographic Distribution of Crohn???s Disease and Ulcerative Colitis in the United States, Clinical Gastroenterology and Hepatology, vol.5, issue.12, pp.1424-1429, 2007. ,
DOI : 10.1016/j.cgh.2007.07.012
Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)., Gut, vol.39, issue.5, pp.39-690, 1996. ,
DOI : 10.1136/gut.39.5.690
Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data, Inflammatory Bowel Diseases, vol.12, issue.3, pp.218-226, 2006. ,
DOI : 10.1053/gast.2003.50021
URL : https://hal.archives-ouvertes.fr/hal-00466309
Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France, Gut, pp.53-843, 1988. ,
Host???microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, vol.286, issue.7422, pp.119-143, 2012. ,
DOI : 10.1074/jbc.M111.291492
Inflammatory Bowel Disease, Stress, and the Endoplasmic Reticulum, New England Journal of Medicine, vol.360, issue.7, pp.726-733, 2009. ,
DOI : 10.1056/NEJMcibr0809591
Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor, New England Journal of Medicine, vol.361, issue.21, pp.2033-2078, 2009. ,
DOI : 10.1056/NEJMoa0907206
Nuclear factor-¬ B ? a pivotal transciption factor in chronic inflammatory diseases, N Engl J Med, vol.15, pp.1066-1071, 1997. ,
The two faces of IKK and NF-??B inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion, Nature Medicine, vol.293, issue.5, pp.575-581, 2003. ,
DOI : 10.1126/science.1062677
Is the Th1/Th2 paradigm of immune regulation applicable to IBD? Inflamm Bowel Dis, Inflamm Bowel Dis, vol.14, issue.2, 2008. ,
TH17 cells in development: an updated view of their molecular identity and genetic programming, Nature Reviews Immunology, vol.178, issue.5, pp.337-385, 2008. ,
DOI : 10.4049/jimmunol.178.6.3822
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD), Clinical & Experimental Immunology, vol.19, issue.3, pp.448-55, 1995. ,
DOI : 10.1016/0016-5085(93)90169-D
??ber Bestandteile der Nebennieren-Rinde VI. Trennungsmethoden, sowie Isolierung der Substanzen F. a. H und J, Helvetica Chimica Acta, vol.111, issue.1, pp.1107-1126, 1936. ,
DOI : 10.1002/hlca.19360190135
Isolation in crystalline form of the hormone essential to life from the suprarenal cortex; its chemical nature and physiologic properties, Mayo Clin Proc, vol.9, pp.245-250, 1934. ,
A physiologic and chemical investigation of the suprarenal cortex, J Biol Chem, vol.114, pp.57-58, 1936. ,
L Rheumatology practice at Mayo Clinic: the first 40 years?, 1920. ,
SIGNIFICANCE OF THE DISCOVERY OF THE EFFECTS OF CORTISONE ON RHEUMATOID ARTHRITIS, The Lancet, vol.256, issue.6620, pp.81-84, 1950. ,
DOI : 10.1016/S0140-6736(50)91038-5
Cortisone and ACTH, The American Journal of Medicine, vol.10, issue.5, pp.567-594, 1951. ,
DOI : 10.1016/0002-9343(51)90329-4
How circulating cytokines trigger the neural circuits that control the hypothalamic???pituitary???adrenal axis, Psychoneuroendocrinology, vol.26, issue.8, pp.761-88, 2001. ,
DOI : 10.1016/S0306-4530(01)00064-6
Cortisone in Ulcerative Colitis, BMJ, vol.2, issue.4947, pp.1041-1049, 1955. ,
DOI : 10.1136/bmj.2.4947.1041
The total synthesis of steroids, J Am Chem Soc, pp.74-4223, 1952. ,
Histoire de la corticoth??rapie, La Revue de M??decine Interne, vol.34, issue.5, pp.258-63, 2013. ,
DOI : 10.1016/j.revmed.2012.12.009
Glucocorticoids and Vascular Reactivity, Current Vascular Pharmacology, vol.2, issue.1, pp.1-12, 2004. ,
DOI : 10.2174/1570161043476483
Evolution of the nuclear receptor gene superfamily, EMBO J, vol.11, pp.1003-1016, 1992. ,
The Origin and Functions of Multiple Human Glucocorticoid Receptor Isoforms, Annals of the New York Academy of Sciences, vol.276, issue.1 ,
DOI : 10.1091/mbc.11.3.799
Antiinflammatory Action of Glucocorticoids ??? New Mechanisms for Old Drugs, New England Journal of Medicine, vol.353, issue.16 ,
DOI : 10.1056/NEJMra050541
Cyclooxygenase isozymes and their gene structures and expression, Prostaglandins & Other Lipid Mediators, vol.68, issue.69, pp.68-6995, 2002. ,
DOI : 10.1016/S0090-6980(02)00024-2
Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1, The EMBO Journal, vol.20, issue.24, pp.7108-7124, 2001. ,
DOI : 10.1093/emboj/20.24.7108
Mechanisms involved in the side effects of glucocorticoids, Pharmacology & Therapeutics, vol.96, issue.1 ,
DOI : 10.1016/S0163-7258(02)00297-8
Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics, Inflammatory Bowel Diseases, vol.132, issue.9, pp.1641-1647, 2012. ,
DOI : 10.1053/j.gastro.2006.11.015
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease, Gut, vol.60, issue.7, pp.930-936, 2011. ,
DOI : 10.1136/gut.2010.227884
Prevalence of and Outcomes Associated with Corticosteroid Prescription in Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.54, issue.4, pp.622-652 ,
DOI : 10.1136/gut.2004.045294
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study, Gastroenterology, vol.121, issue.2, pp.255-60, 2001. ,
DOI : 10.1053/gast.2001.26279
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management, Journal of Crohn's and Colitis, vol.80, issue.Suppl. III, pp.991-1030, 2012. ,
DOI : 10.1159/000212075
A Comparison of Budesonide with Prednisolone for Active Crohn's Disease, New England Journal of Medicine, vol.331, issue.13, pp.842-847, 1994. ,
DOI : 10.1056/NEJM199409293311304
Regulation of cytokine and cytokine receptor expression by glucocorticoids, Journal of Leukocyte Biology, vol.60, issue.5, pp.563-72, 1996. ,
DOI : 10.1002/jlb.60.5.563
Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients, Gastroenterology, vol.125, issue.2, pp.320-327, 2003. ,
DOI : 10.1016/S0016-5085(03)00883-7
Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in Belgium, Acta Gastro- Enterol Belg. mars, vol.73, issue.1, pp.41-46, 2010. ,
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease, Journal of Crohn's and Colitis, vol.8, issue.6, pp.443-68, 2014. ,
DOI : 10.1016/j.crohns.2013.12.013
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management, Journal of Crohn's and Colitis, vol.136, issue.S1, pp.28-62, 2010. ,
DOI : 10.1007/s00384-008-0542-9
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease, New England Journal of Medicine, vol.369, issue.8, 2013. ,
DOI : 10.1056/NEJMoa1215739
Baumelou A, « Situation de l'automédication en France et perspectives d'évolution ,
Information et automédication, 2001. ,
Risks of Self-Medication Practices, Current Drug Safety, vol.5, issue.4, pp.315-338, 2010. ,
DOI : 10.2174/157488610792245966
Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut, pp.360-362, 1994. ,
Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial, The Lancet, vol.358, issue.9286, pp.976-81, 2001. ,
DOI : 10.1016/S0140-6736(01)06105-0
Cross-sectional descriptive study of topical self-medication in a hospital dermatology department in the state of S??o Paulo, Anais Brasileiros de Dermatologia, vol.32, issue.1, pp.163-168, 2012. ,
DOI : 10.1590/S0034-89101998000100006
Prevalence of self-medication for skin diseases: a systematic review, Anais Brasileiros de Dermatologia, vol.44, issue.4, pp.625-655, 2014. ,
DOI : 10.1590/S0034-89102010000400002
Autom??dication et dermatoses aigu??s : ??tude prospective de 111 malades hospitalis??s, Annales de Dermatologie et de V??n??r??ologie, vol.132, issue.4, pp.372-375, 2005. ,
DOI : 10.1016/S0151-9638(05)79287-5
The effect of immune therapy on surgical site infection following Crohn's Disease resection, British Journal of Surgery, vol.19, issue.Suppl, pp.1089-93 ,
DOI : 10.1111/j.1365-2036.2004.01904.x
Over-the-counter migration of steroid use, Current Opinion in Allergy and Clinical Immunology, vol.14, issue.5, pp.471-477, 2014. ,
DOI : 10.1097/ACI.0000000000000099
Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future development, Journal of Medical Economics, vol.16, issue.6, pp.835-879, 2013. ,
DOI : 10.3111/13696998.2013.793693
E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ???Constant-care??? approach, Gut, vol.59, issue.12, pp.1652-61, 2010. ,
DOI : 10.1136/gut.2010.220160
The doses of the induction treatment are shown in Table ,
Prevalence of and Outcomes Associated with Corticosteroid Prescription in Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.54, issue.4, pp.622-652, 2014. ,
DOI : 10.1136/gut.2004.045294
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management, Journal of Crohn's and Colitis, vol.80, issue.Suppl. III, pp.991-1030, 2012. ,
DOI : 10.1159/000212075
European Crohn's and Colitis Organisation (ECCO) The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management, J Crohns Colitis, vol.4, pp.28-62, 2010. ,
Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics, Inflamm Bowel Dis, vol.18, pp.1641-1647, 2012. ,
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease, Gut, vol.60, issue.7, pp.930-936, 2011. ,
DOI : 10.1136/gut.2010.227884
Risks of Self-Medication Practices, Current Drug Safety, vol.5, issue.4, pp.315-338, 2010. ,
DOI : 10.2174/157488610792245966
A Comparison of Budesonide with Prednisolone for Active Crohn's Disease, New England Journal of Medicine, vol.331, issue.13, pp.842-847, 1994. ,
DOI : 10.1056/NEJM199409293311304
Mechanisms involved in the side effects of glucocorticoids, Pharmacology & Therapeutics, vol.96, issue.1 ,
DOI : 10.1016/S0163-7258(02)00297-8
Frequency of glucocorticoid resistance and dependency in Crohn's disease., Gut, vol.35, issue.3, pp.360-362, 1994. ,
DOI : 10.1136/gut.35.3.360
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study, Gastroenterology, vol.121, issue.2, pp.255-60, 2001. ,
DOI : 10.1053/gast.2001.26279
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis, Journal of Crohn's and Colitis, vol.8, issue.76, pp.965-90, 2012. ,
DOI : 10.1097/00054725-200201000-00003
Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial, The Lancet, vol.358, issue.9286, pp.976-81, 2001. ,
DOI : 10.1016/S0140-6736(01)06105-0
Cross-sectional descriptive study of topical self-medication in a hospital dermatology department in the state of S??o Paulo, Anais Brasileiros de Dermatologia, vol.32, issue.1, pp.163-168, 2012. ,
DOI : 10.1590/S0034-89101998000100006
Prevalence of self-medication for skin diseases: a systematic review, Anais Brasileiros de Dermatologia, vol.44, issue.4, pp.625-655, 2014. ,
DOI : 10.1590/S0034-89102010000400002
Autom??dication et dermatoses aigu??s : ??tude prospective de 111 malades hospitalis??s, Annales de Dermatologie et de V??n??r??ologie, vol.132, issue.4, pp.372-375, 2005. ,
DOI : 10.1016/S0151-9638(05)79287-5
The effect of immune therapy on surgical site infection following Crohn's Disease resection, British Journal of Surgery, vol.19, issue.Suppl, pp.1089-93, 2013. ,
DOI : 10.1111/j.1365-2036.2004.01904.x
Over-the-counter migration of steroid use, Current Opinion in Allergy and Clinical Immunology, vol.14, issue.5, pp.471-477, 2014. ,
DOI : 10.1097/ACI.0000000000000099
Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future development, Journal of Medical Economics, vol.16, issue.6, pp.835-879, 2013. ,
DOI : 10.3111/13696998.2013.793693
E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ???Constant-care??? approach, Gut, vol.59, issue.12, pp.1652-61, 2010. ,
DOI : 10.1136/gut.2010.220160